China's Kangmei Pharmaceuticals annual revenue 2016-2020
In 2020, Kangmei Pharmaceuticals recorded a nearly 5.4 billion yuan annual revenue, indicating a 52.7 percent of loss compared to the previous year. The Shenzhen-based enterprise, one of the largest national pharmaceutical groups in China, offers a wide range of Chinese medicines, chemical drugs and health food products.